Handelsbanken Fonder AB »

Intra Cellular Therapies shares owned by Handelsbanken Fonder AB

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Handelsbanken Fonder AB from 13F filings

Historical chart of Handelsbanken Fonder AB investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Handelsbanken Fonder AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Handelsbanken Fonder AB

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.3M 19k 71.62
2023-09-30 $906k 17k 52.07
2023-06-30 $975k 15k 63.31
2023-03-31 $639k 12k 54.15
2022-12-31 $624k 12k 52.88
2022-09-30 $549k 12k 46.53
2022-06-30 $674k 12k 57.12
2022-03-31 $722k 12k 61.19
2021-12-31 $806k 15k 52.34
2021-09-30 $574k 15k 37.27
2021-06-30 $629k 15k 40.84
2021-03-31 $387k 11k 33.95
2020-12-31 $363k 11k 31.84
2020-09-30 $293k 11k 25.70
2020-06-30 $293k 11k 25.70